Product platform

a bottle with chemicals In recent years histone research has revealed a multitude of biological functions of this protein family outside the cell nucleus. In addition to their function as defence molecules against endogenous and exogenous pathogens, they perform systemic hormonal and signaling functions outside the cell. SymbioTec’s broad patent portfolio provides a basis for utilizing several of these features in therapy and diagnosis. At present SymbioTec is focusing on cancer.

AML

AML

The first product, ONCOHIST is being developed for Acute Myeloid Leukaemia (AML).

Leukemia

Leukemia

The three other main types of leukaemia (ALL, CML, CLL) will be studied in the next planned clinical trials.

Breast cancer

Breast cancer

Breast cancer is planned to be included in the next clinical trials.

Other cancers

Other cancers

Studies on cell lines and animal models prove the potential of histone-related drugs in many other cancer types.

Diagnostic

Diagnostic

The diagnostic tools based on histone-derived technology have a great potential to develop personalised medical treatments.